TMO stock

Thermo Fisher Scientific Inc (TMO) earnings · P/E 36, rev $44.56B

These earnings events as JSON? API free 100/day

Thermo Fisher Scientific Inc (TMO) is a diagnostics & research company listed on US. It is led by Marc N. Casper.

This TMO earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.

Latest reported TMO revenue for 2025-12-31 was $44.56B. Net income was $6.70B. Revenue was up 3.9% from 2024-12-31 to 2025-12-31. TMO currently screens at market cap $153.06B and trailing P/E 36.3.

When the next TMO 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.

The change that matters: Revenue was up 3.9% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.

Not investment advice. Full TMO research stays on the stock page; the tape stays on the quote page.

TMO earnings FAQ

What are TMO's latest revenue and net income?

Latest cached Thermo Fisher Scientific Inc (TMO) revenue for Dec 31, 2025 was $44.56B. Net income was $6.70B. Statements: https://lician.com/financials/tmo

What is TMO's latest diluted EPS?

Latest cached Thermo Fisher Scientific Inc (TMO) diluted EPS for Dec 31, 2025 was $17.74.

What period does the latest TMO earnings print cover?

The latest cached Thermo Fisher Scientific Inc (TMO) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.

How did TMO revenue change from the prior cached period?

Cached Thermo Fisher Scientific Inc (TMO) revenue was up 3.9% from $42.88B (Dec 31, 2024) to $44.56B (Dec 31, 2025). Statements: https://lician.com/financials/tmo

What is TMO's P/E ratio?

Thermo Fisher Scientific Inc (TMO) trailing P/E is 36.3 on the latest cached fundamentals snapshot.

Where are TMO earnings listed?

Cached earnings facts for Thermo Fisher Scientific Inc (TMO) are listed at https://lician.com/earnings/tmo. Statements: https://lician.com/financials/tmo

Not investment advice.

Full TMO analysis